|
Volumn 31, Issue 3, 1992, Pages 229-239
|
Evaluation of 9-dimethylaminomethyl-10-hydroxycamptothecin against xenografts derived from adult and childhood solid tumors
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CAMPTOTHECIN DERIVATIVE;
MELPHALAN;
TOPOTECAN;
VINCRISTINE;
ADULT;
ANIMAL EXPERIMENT;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CHILD;
CHILDHOOD CANCER;
CONTROLLED STUDY;
DRUG RESISTANCE;
HUMAN;
HUMAN CELL;
INTRAPERITONEAL DRUG ADMINISTRATION;
MOUSE;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
TUMOR XENOGRAFT;
ADENOCARCINOMA;
ADULT;
ANIMAL;
ANTINEOPLASTIC AGENTS;
CAMPTOTHECIN;
CHILD;
COLONIC NEOPLASMS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG EVALUATION, PRECLINICAL;
FEMALE;
HUMAN;
MICE;
MICE, INBRED CBA;
NEOPLASM TRANSPLANTATION;
OSTEOSARCOMA;
REMISSION INDUCTION;
RHABDOMYOSARCOMA;
SUPPORT, NON-U.S. GOV'T;
SUPPORT, U.S. GOV'T, P.H.S.;
TIME FACTORS;
TOPOTECAN;
TUMOR CELLS, CULTURED;
|
EID: 0026487210
PISSN: 03445704
EISSN: 14320843
Source Type: Journal
DOI: 10.1007/BF00685553 Document Type: Article |
Times cited : (221)
|
References (36)
|